Genomic alterations in breast cancer: Level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

1. Condorelli, R.
2. Mosele, F.
3. Verret, B.
4. Bachelot, T.
5. Bedard, P.L.
6. Cortes, J.
7. Hyman, D.M.
8. Juric, D.
9. Krop, I.
10. Bieche, I.
11. Saura, C.
12. Sotiriou, C.
13. Cardoso, F.
14. Loibl, S.
15. Andre, F.
16. Turner, N.C.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/ANNONC/MDZ036 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus